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BACKGROUND: Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease, known to be associated with a markedly
increased risk of colorectal carcinoma development.
METHODS: Using proteomic analysis with two-dimensional gel electrophoresis and mass spectrometry, differentially expressed proteins
were assessed between UC-associated cancer and sporadic colon cancer cell lines. Western blot and immunostaining were
performed for confirming the expression.
RESULTS: Heat-shock protein of 47kDa (HSP47) was identified as one of the proteins expressed more highly in UC-associated cancer
cell lines, and an immunohistochemical examination confirmed significantly higher levels of HSP47 in UC-associated colon cancers
than in sporadic counterparts, the expression increasing with a progression of neoplastic lesions. Heat-shock protein of 47kDa was
further found to be coexpressed with type I collagen in the cytoplasm, and both HSP47 and type I collagen were released from
cultured cells into the culture medium.
CONCLUSION: These results suggest that overexpression of HSP47 is a unique characteristic of UC-associated carcinoma related to
type I collagen synthesis, with possible clinical applications.
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Recently, carcinogenesis pathways driven by chronic inflammation
have been proposed, with ulcerative colitis (UC)-associated
colorectal cancer as one very concrete example (Wong and
Harrison, 2001; Okayasu et al, 2002). Ulcerative colitis features
chronic, relapsing, and debilitating idiopathic inflammation of the
colon mucosa and submucosa, and patients with long-standing UC
are at high risk of neoplastic development. Ulcerative colitis-
associated carcinomas are often difficult to detect endoscopically
and to discriminate from inflammatory regenerative epithelium
(Sada et al, 2004; Fujii et al, 2008); hence, a molecular marker is
urgently required. Recently, proteomics for large-scale studies of
gene expression at the protein level have been viewed as a
promising experimental approach to explore the control of
biological processes and pathways (Lawrie et al, 2001; Dundas
et al, 2005; Kuruma et al, 2005). In this study, using UC-associated
cancer cell lines and sporadic colorectal cancer cell lines
established by our group (Yamashita et al, 2004), we sought to
determine proteins expressed differently between the two cell lines,
using proteomics methods. Agarose two-dimensional gel electro-
phoresis (agarose 2-DE) and liquid chromatography-tandem mass
spectrometry (LC-MS/MS) allowed the detection of heat-shock
protein of 47kDa (HSP47) as one protein showing an over-
expression in UC-associated cancer cell lines. Heat-shock protein
of 47kDa is a molecular chaperone that recognises collagen triple
helices in the endoplasmic reticulum (ER) (Nagata et al, 1986;
Nakai et al, 1992). Usually, its expression is closely related to that
of collagen in collagen-secreting cells, such as fibroblasts. In this
study, this expression was further explored in cancer cell lines and
immunohistochemically in colon cancer tissues.
MATERIALS AND METHODS
Cell culture
Ulcerative colitis-associated cancer cell lines, UCCA-3, UCCA-21,
and UCCA-24, and sporadic colorectal cancer cell lines, KE-24,
KE-43P, and KE-43W, were earlier established in our laboratory
(Yamashita et al, 2004). Cell lines UCCA-3, UCCA-21, UCCA-24,
KE-43P, and KE-43W were cultured in Dulbecco’s modified Eagle’s
medium (Gibco, Carlsbad, CA, USA), and cell line KE-24 was
cultured in RPMI medium 1640 (Gibco), supplemented with 10%
fetal bovine serum and 1% penicillin–streptomycin (Gibco), at
371C in an atmosphere of 5% CO2 and 95% air in a humidified
incubator. When the cells reached the logarithmic growth phase,
they were washed with phosphate-buffered saline (PBS), scraped
off into a tube, briefly centrifuged, quickly frozen in liquid
nitrogen, and stored at  801C until use. Primary cultures of
Received 30 March 2009; revised 28 May 2009; accepted 5 June 2009;
published online 14 July 2009
*Correspondence: K Araki, Department of Pathology, Kitasato University
School of Medicine, 1-15-1, Kitasato, Sagamihara, Kanagawa 228-8555,
Japan. E-mail: dm07003o@st.kitasato-u.ac.jp
British Journal of Cancer (2009) 101, 492–497
& 2009 Cancer Research UK All rights reserved 0007– 0920/09 $32.00
www.bjcancer.com
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
shuman fibroblasts were kindly provided by Dr Y Kuroyanagi (R&D
Center for Artificial Skin, School of Allied Health Sciences,
Kitasato University, Kanagawa, Japan) and similarly cultured in
Dulbecco’s modified Eagle’s medium (Gibco).
Protein extraction
The cell pellets were sonicated in an extraction solution containing
7 M urea, 2 M thiourea, 0.1 M dithiothreitol, 2.5% pharmalyte (pH
3–10), 2% CHAPS, and Complete Mini EDTA-free (protease
inhibitors, Roche Diagnostics, Mannheim, Germany). After
centrifugation at 15000r.p.m. for 20min, the supernatant was
recovered and the protein concentration was measured using a DC
Protein Assay kit (Bio-Rad Laboratories, Hercules, CA, USA).
Proteomic analysis
Proteomic analysis was carried out using agarose 2-DE according to
previously published protocols by Oh-Ishi et al (2000) (Tomonaga
et al, 2004). The agarose isoelectric focusing gel for the first
dimension (180mm in length and 3.4mm in inner diameter) was
prepared by stratification of three types of pharmalyte (pH 2.5–5
for acidic, pH 3–10 and pH 4–6.5 for neutral, and pH 8–10.5 for
basic solution). The second dimension for SDS–PAGE used 12%
polyacrylamide gels (200 130 1.3mm). Cell lysates, equivalent
to 500mg of extracted protein, were subjected to all steps of 2-DE,
including agarose isoelectric focusing SDS–PAGE, Coomassie
Brillant blue staining, and quantitative analysis using Scion Image
(Windows version of public domain NIH image program) (Scion
Corporation, Frederick, MD, USA). Protein spots with more than
two-fold differences in protein intensity were cut from gels and
digested with trypsin to produce unique sets of tryptic fragments.
The masses of these fragments were determined using the LC-MS/
MS system, consisting of an HPLC system (Nanospace SI-2,
Shiseido Fine Chemicals, Tokyo, Japan) and an ion-trap mass
spectrometer (LCQ-Deca, Thermo Finnigan, San Jose, CA, USA). A
minimum score of 80 was selected as the criterion for the positive
identification of proteins. We used the database of the SEQUEST
program (an attached software to the LQC-Deca, Thermo Finnigan,
San Jose, CA, USA) to identify proteins from measured masses of
tryptic peptides and their MS/MS fragments.
Western blot analysis
Protein samples (5mg) were separated by SDS–PAGEelectrophor-
esis using 10% gels, and blotted onto Hybond-P, PVDF membranes
(Amersham Pharmacia Biotech, Buckinghamshire, UK). Immu-
noassays were performed using anti-HSP47 (monoclonal, SPA-470,
1:10000, Stressgen Biotechnologies, Ann Arbor, MI, USA) and
anti-b-actin (monoclonal, AC-15, 1:10000, Sigma, St Louis, MO,
USA) antibodies. The membranes were then incubated with anti-
mouse immunoglobulin-HRP (DakoCytomation, Glostrup, Den-
mark), and protein bands were visualised using enhanced
chemiluminescence (Amersham Pharmacia Biotech) according to
the manufacturer’s manual.
Immunocytochemical staining
The harvested cells were washed and re-suspended in PBS and
centrifuged at 1000r.p.m. for 5min using Cytospin 2 (Thermo
Fisher Scientific Inc., Waltham, MA, USA). Cells on slide
glasses were immediately immersed in 95% ethanol, and
immunocytochemical staining was performed using the labelled
polymer–peroxidase complex method (EnVisionþ System HPR;
DakoCytomation). Endogenous peroxidase was blocked using
0.3% hydrogen peroxide for 30min. After incubation with Protein
Block Serum-Free (DakoCytomation), sections were incubated
overnight with an anti-HSP47 antibody (monoclonal, SPA-470,
1:1000, Stressgen Biotechnologies) at 41C. After incubation with a
labelled polymer (anti-mouse, EnVisionþ System HPR; DakoCy-
tomation) for 10min at room temperature, 3,30-diaminobenzidine
was used as the chromogen. Nuclei were counter-stained with 0.3%
methylgreen solution.
Immunohistochemical staining
From the pathology files of the Kitasato University Hospital and
the Kitasato University East Hospital, cases of 63 UC-associated
lesions and 81 sporadic colon tumour lesions were collected. Given
that almost all UC-associated neoplastic lesions were located at the
left hemicolon, sporadic colon tumours were mainly collected from
cases of the left hemicolon. The clinicopathological data of the
cases included in this study are summarised in Table 1. Formalin-
fixed paraffin-embedded tissue blocks of specimens of 16 UC-
associated low-grade dysplasias (LGDs), 12 high-grade dysplasias
(HGDs), 10 invasive adenocarcinomas, and 25 areas of inflamma-
tory regenerative mucosa, and of 17 cases of sporadic tubular
adenoma with LGD, 16 cases of sporadic tubular adenoma with
HGD, and 48 cases of sporadic invasive adenocarcinoma were then
collected. In addition, 48 normal control mucosa specimens
collected at least 5-cm distant from sporadic cancer lesions were
also examined. Serial 4-mm-thick sections were cut for immuno-
histochemical staining using an EnVisionþ kit (EnVisionþ
System HPR; DakoCytomation) and anti-HSP47 antibodies at the
working dilution (SPA-470, 1:200, Stressgen Biotechnologies).
Table 1 Clinicopathological data of the patients
Carcinoma
Age (years)
(mean±s.d.) Gender (M:F)
Duration from the onset of
UC (years) (mean±s.d.) Site (R:L)
Differentiation
(well:mod-poor)
Stage
a
(I:II:III:IV)
UC-associated lesions
UC regenerative mucosa 39.1±14.2 13:13 6.4±5.4 1:25
UC low-grade dysplasia 37.5±15.1 6:9 9.7±2.5 0:16
UC high-grade dysplasia 42.3±16.1 10:2 12.1±4.0 0:12
UC-associated Ca 33.4±14.6 3:6 9.5±4.4 0:10 3:7 1:2:7:0
Sporadic colon tumour
Normal mucosa 63.3±12.3 26:22 0:48
Adenoma, low grade 57.8±14.3 13:3 0:15
Adenoma, high grade 69.2±9.0 10:5 0:15
Adenocarcinoma 63.3±12.3 26:22 0:48 18:30 3:13:32:0
Ca¼carcinoma; F¼female; L¼left; M¼male; mod-poor¼moderate to poor; R¼right; UC¼ulcerative colitis.
aAccording to Unio Internationalis Contra Cancrum (UICC)
criteria (Sobin and Wittekind, 2002).
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sEndogenous peroxidase was blocked by 0.3% hydrogen peroxide
for 30min. After incubation with Protein Block Serum-Free
(DakoCytomation), sections were incubated overnight with anti-
HSP47 antibody at 41C. After incubation with a labelled polymer
(anti-mouse, EnVisionþ System HPR; DakoCytomation) for
30min at room temperature, 3,30-diaminobenzidine was used as
the chromogen. Nuclei were counter-stained using Mayer’s
haematoxylin to facilitate histopathological assessment. Immuno-
reactivity for HSP47 was evaluated using the scoring system as
previously described (Tokuyama et al, 2007), combining staining
intensity (none, 0; weak, 1; moderate, 2; intense, 3) with
percentages of positive cells (0, o1%; 1, 1–25%; 2, 25–50%; 3,
50–75%; 4, 475%).
Double immunofluorescence staining of cell lines
A UC-associated cancer cell line (UCCA-3) and a sporadic
carcinoma cell line (KE-24) were cultured on chamber glass slides
(Thermo Fisher Scientific Inc.), fixed with 50% methanol and 50%
acetone for 5min, and permeabilised in 0.1% Triton X-100 in PBS
for 5min. The slides were then incubated with anti-monoclonal
HSP47 antibody (SPA-470, 1:200, Stressgen Biotechnologies) for
1h at room temperature. After washing, anti-collagen type I
polyclonal antibodies (COL-1, 1:500, Sigma) were applied for 1h
at room temperature. The secondary antibodies were rhodamin-
labelled anti-mouse IgG and fluorescein isothiocyanate (FITC)-
labelled anti-rabbit IgG (both 1:500, Molecular Probes, Leiden,
The Netherlands), for 30min at room temperature. Cell nuclei
were counter-stained with DAPI. Negative control staining
was performed by omitting the primary antibody incubation.
Immediately after treatment, the cell lines were observed under a
fluorescence microscope.
ELISA for measuring type I collagen concentrations in
culture media
Cell lines UCCA-3, UCCA-21, UCCA-24, KE-24, KE-43P, and KE-
43W were cultured in 24-well plates with 1ml of the culture
medium. A human collagen type I ELISA kit (Applied Cell
Biotechnologies Inc., Yokohama, Japan) was used to measure the
concentration of type I collagen in the culture medium. When the
cells reached confluence, 0.2ml of the culture medium and 0.1ml
of pepsin solution (pepsin 0.6mgml
 1 dissolved in 150mM acetic
acid) were mixed, and collagen was digested overnight at 41C.
Biotinylated anti-type I collagen antibodies were then added and
50ml aliquots of the mixture were applied to microplate wells on
which type I collagen was immobilised. After incubation for 1h at
room temperature and washing, an avidin-horseradish peroxidase
conjugate solution was added to the wells, followed by incubation
for 1h at room temperature. After washing, 50ml of substrate
solution was added, and after incubation for 15min at room
temperature, 50ml of stop solution (1 N H2SO4) was added. The
concentration of collagen type I was obtained by measuring
absorbance at 450nm on a microplate reader.
Western blotting of HSP47 in cell culture medium
Cell lines were cultured in 12-well plates in 2ml of the culture
medium. When they reached confluence, the culture medium was
replaced with a serum-free BIO-RICH 1 medium (MP Biomedicals,
Irvine, CA, USA) for 4 days. Samples were collected, and 3ml of
extract solution (7 M urea, 2 M thiourea, 0.1 M dithiothreitol) was
added for overnight incubation at 41C. After the solutions were
concentrated by acetone precipitation, HSP47 was detected by
western blot analysis. As a negative control, the culture medium
alone was used.
Statistical analysis
All statistical tests were conducted using StatView 5.0 software
(SAS institute Inc., Cary, NC, USA). Comparisons among more
than two groups were assessed using the Kruskal–Wallis test with
the Mann–Whitney U-test as a post hoc test. Comparisons between
two groups were made using the Mann–Whitney U-test. Statistical
significance was concluded at Po0.05.
RESULTS
Proteomic analysis
Representative agarose 2-DE images are shown in Figure 1A.
A total of more than 2000 spots were obtained, 67 being
differentially expressed between UC-associated cancer and spora-
dic colorectal cancer cell lines. Of the 67 spots, 2 protein spots
showed a more than 2-times higher expression and 4 spots showed
a more than 2-times lower expression in all 3 UC-associated cancer
cell lines than in all 3 sporadic cancer cell lines. On tryptic
digestion and LC-MS/MS system analysis, six proteins were
identified. Heat-shock protein of 47kDa was detected as one
protein consistently expressed higher in three UC-associated
cancer cell lines than in three sporadic colorectal cancer cell lines
(Figure 1B). Another protein that showed a higher expression in
UC-associated cell lines was a cytoskeletal protein. Four proteins
that showed a higher expression in sporadic cancer cell lines were
a cytoskeletal protein, a signal transduction factor, and two
enzymes associated with acetyl-coA metabolism and folate
metabolism. In addition, HSP70 was detected as a protein that
showed a tendency to increase in two UC cell lines, significant
difference not being recognised.
(KDa) pH 10  ←→   pH 3
200
UCCA-3 UCCA-21 UCCA-24
UC-Ca
Sp-Ca
KE-43W KE-43P KE-24
116
97
65
45
31
Figure 1 Agarose two-dimensional electrophoresis gel patterns of cell lines. (A) Representative proteome maps derived from the UCCA-3, UC-
associated cancer cell line. The red circle indicates the protein spot, HSP47. (B) The zoomed two-dimensional electrophoresis gel images show expression
of HSP47. UC-associated cancer cell lines show an increased expression of HSP47 compared with sporadic cancer cell lines (Coomassie blue-stained two-
dimensional electrophoresis gels).
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sHSP47 expression by western blot analysis and
immunocytochemical staining
Upregulation of HSP47 in UC-associated cancer cell lines by
proteomics analysis was further confirmed using immunoblotting
(Figure 2A) and immunocytochemical staining (Figure 2B). With
immunocytochemical staining, the HSP47 protein was expressed in
the cytoplasm of the cells.
HSP47 expression in UC-associated and sporadic colon
tumours
Typical HSP47 immunohistochemical staining patterns of UC-
associated lesions are shown in Figure 3. The expression of HSP47
was lacking or very weak in normal epithelial cells. In tumour
tissue, staining was evident in the cytoplasm of epithelial tumour
cells. Both UC-associated and sporadic colon tumours showed a
significantly higher expression than did normal mucosa. In
addition, HSP47 tended to gradually increase from low-grade
intramucosal lesions, dysplasia, and adenoma towards invasive
carcinoma, in both series. Furthermore, UC-associated carcinoma
showed a higher expression than did sporadic colonic carcinoma
(Po0.01), and UC-regenerative mucosa showed a significantly
higher expression than did normal mucosa (Po0.05) (Figure 4).
When UC-regenerative mucosae were histologically classified into
active and inactive UC groups, there was no difference in
expression between the two groups (active UC, 1.0±0.7; inactive
UC, 1.0±0.8).
Immunofluorescent double staining of HSP47 and type I
collagen
Immunofluorescent double staining of HSP47 and type I collagen
showed co-localisation in UC-associated cancer cell lines
(Figure 5). In contrast, no or only a weak expression of type I
collagen was found in sporadic colorectal cancer cell lines.
Type I collagen synthesis measured by ELISA
Type I collagen synthesis was shown in both UC-associated and
sporadic colorectal cancer cell lines, as well as in human
fibroblasts. However, compared with UC-associated cancer cell
lines, collagen synthesis was at a low level in the KE 24 and KE43W
cell lines (Figure 6).
UC-Ca
HSP 47
UCCA-3
UC-Ca
KE-24
Sp-Ca
KE-43P KE-43W
UCCA-21 UCCA-24
-Actin
Sp-Ca
KE
43W
KE
43P
KE
24
UCCA
3
UCCA
21
UCCA
24
Figure 2 Western blot analysis of the HSP47 expression in cell lines.
(A) UC-associated cancer cell lines (UC-Ca) and sporadic cancer cell
lines (Sp-Ca). b-Actin expression was used as a control. (B) Immuno-
cytochemical staining of HSP47 in the six cell lines. The strong reactions in
UC-associated cancer cell lines is noted.
Normal UC regenerative UC LGD UC HGD UCCA
Figure 3 Immunohistochemical staining of HSP47 in tissues. (A) UC-associated lesions and normal mucosa. Normal epithelial cells are not stained for
HSP47. It is noted that the increased expression of HSP47 with progression through to carcinoma is apparent. (B) A higher magnification of the boxed area
is shown in panel A. UCLGD, UC low-grade dysplasia; UCHGD, UC, high-grade dysplasia; UCCA, UC-associated adenocarcinoma.
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HSP47 was detected by immunoblotting in the culture media,
particularly from UC-associated cancer cell lines. There was
an extremely limited release from normal human fibroblasts
(Figure 7).
DISCUSSION
Proteomic analysis of UC-associated cancer cell lines and sporadic
colorectal cancer cell lines in this study showed an upregulated
expression of the ER stress-response protein HSP47 in UC-
associated cancer cell lines. In the culture environment, as neither
inflammation nor influence of stroma exists, protein expression is
limited. Therefore, we confirmed the expression using clinical
materials by immunohistochemical staining. The expression of
HSP47 increased with progression through dysplasia to UC-
associated carcinoma. Heat-shock protein of 47kDa is a collagen-
binding, stress-inducible protein localised in the ER that
participates in the intracellular processing, folding, assembly,
and secretion of procollagens, especially in collagen-secreting cells,
such as fibroblasts, for example, in fibrotic lesions (Razzaque and
Taguchi, 1999). On the other hand, in epithelial or carcinoma cells,
few reports have described the expression of HSP47. Our results
are in line with earlier reports of overexpression of HSP47 in
pancreatic carcinoma (Maitra et al, 2002), gastric carcinoma (Hirai
et al, 2006), and head and neck squamous cell carcinoma (Li et al,
2008). Another chaperone protein, mortalin (mitochondrial heat-
shock protein 70), was reported as the protein that contributed to
colorectal adenocarcinomas (Dundas et al, 2005). Heat-shock
protein of 47kDa has an important role in the biosynthesis of
procollagens, and co-localisation of HSP47 and collagen type I
could be shown by double immunofluorescent staining in this
study. In tissue, although HSP47 was found to be expressed in both
epithelial and stromal cells within cancers, only the former showed
an increase with progression to greater malignancy. A significantly
higher expression in UC-associated than in sporadic carcinomas
a
b b
b
c
a : P<0.05
b : P<0.01
c : P<0.001
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Figure 4 The epithelial expression of HSP47 in UC-associated (open
bars) and sporadic colon tumour lesions (hatched bars). Data are mean
scores and s.d. (a) Po0.05; (b) Po0.01; and (c) Po0.001; LGD, low-grade
dysplasia; HGD, high-grade dysplasia.
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Figure 5 Double immunofluorescence staining for HSP47 (red-
rhodamin) and type I collagen (green-FITC) in a UC-associated cancer
cell line (UCCA-3) and a sporadic cancer cell line (KE-24). The cells were
counterstained with DAPI to visualise the nuclei.
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Figure 6 Collagen synthesis of UC-associated cancer cell lines (UC-Ca)
(open bars), sporadic cancer cell lines (Sp-Ca ) (hatched bars), and human
fibroblast cells (black bars). Data are given as concentrations of type I
collagen in medium. Vertical lines show s.d.
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Control
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Figure 7 Western blot of HSP47 in cell culture medium. An increased
release of HSP47 was shown in UC-associated cancer cell lines than in
sporadic colorectal cancer cell lines.
HSP47 in colitic cancer
K Araki et al
496
British Journal of Cancer (2009) 101(3), 492–497 & 2009 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
ssuggests that the epithelial expression of HSP47 may be influenced
by background inflammation. However, as upregulation was also
noted in cultured UC-associated cancer cell lines, the increase may
be an intrinsic property.
In culture media, type I collagen was detected. Therefore, not
only fibroblasts but also epithelial cancer cells produce type I
collagen. Although the functions of collagen from epithelial cells
are not clear, they may reflect stromal collagen metabolism. From
the literature, inflammatory cytokine production during chronic
inflammation may lead to excessive collagen deposition and
eventually to fibrosis in UC (Lawrance et al, 2001a,b). Metallo-
proteinases may also be overexpressed and degrade stromal
collagen with inflammatory bowel disease (von Lampe et al,
2000; Stumpf et al, 2006). Therefore, in chronic inflammatory
condition, the biosynthesis of collagen might need to be increased
chronically, with collagen produced by epithelial cells supplement-
ing that from fibroblasts.
Heat-shock protein of 47kDa clearly has the potential to be a
biomarker for UC-associated cancer. Although the mechanism of
release from cancer cell remains to be clarified, cell death could be
involved. Alternatively, a deletion of the ER retention signal or an
overflow of HSP47 from the ER retention signal may cause a
leakage of HSP47 to outside the cell (Yokota et al, 2003). Only very
limited release was noted from cultured fibroblasts. Recently, high-
serum auto-antibodies to HSP47 or HSP47 itself have been
reported under inflammatory conditions, such as interstitial
pneumonia and mixed connective tissue disease (Yokota et al,
2003; Kakugawa et al, 2008). If HSP47 is released from cancers in
patients with UC, its detection in serum would be helpful for the
clinical detection of malignancy. As surveillance by endoscopic
examination sometimes fails to detect cancer lesions (Fujii et al,
2008), an easily measurable biomarker would clearly be very
welcome.
In conclusion, overexpression of HSP47 is a unique character-
istic of UC-associated carcinoma. Further studies are required to
elucidate its clinical significance.
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